WILMORE, Ky. (WKYT) - A Wilmore woman made quite the discovery after receiving results from a DNA kit, one that would lead to ...

A recent large-scale study published in Science Advances has revealed a connection between genetic variations associated with ...

AI-driven genomics startups leverage technology to analyze genetic data, predict predispositions, and offer personalized ...

Provides 23andMe+ Premium members with insight into their likelihood of developing osteoporosis based on thousands of genetic ...

The latest unsurprising development in 23andMe’s story is the admission, by their new board of directors, that 23andMe now does not have enough cash to continue for the next 12 months. They are now ...

The testing company ended last year with $79 million and told investors it will need to raise money to fund its operations ...

By the 2023 fiscal year, 23andMe had reported a net loss of $312 million and its individual share price has plummeted a ...

A pioneer in genetic heritage services, 23andMe has seen much of its share price wiped out in the past year as it struggles ...

Em­bat­tled ge­net­ics test­ing gi­ant 23andMe is think­ing of sell­ing it­self as it runs out of cash. The com­pa­ny needs ...

Genetic testing pioneer 23andMe is looking at strategic alternatives, including a possible sale, it said Tuesday, months ...

Manhattan Associates' 2025 outlook missed estimates. The provider of supply-chain and omnichannel-commerce solutions said it expects adjusted per-share earnings of $4.45 to $4.55 on revenue of $1.06 ...

SUNNYVALE, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- The Special Committee of the Board of Directors of 23andMe Holding Co. (Nasdaq: ME) ("23andMe" or the "Company"), a leading human genetics company ...